2 surprisingly good old anti-cancer drugs when used together

UK scientists have discovered a series of tumor-resistant forms of cancer that can be easily suppressed simply by taking two long-term common drugs at the same time.

Drug-resistant tumors are a problem for cancer doctors because studying a new remedy is extremely difficult and takes years. However, British scientists at University College London (UCL) and the Institute of Cancer Research (ICR) have suddenly found an easier way: combining two drugs that have been popular on the market for a long time is Palbociclib treatment of breast cancer and crizotinib treatment of lung cancer .

Drug resistant breast cancer is a major challenge for scientists - (artwork from the internet).

According to Professor Paul Workman, ICR executive director and professor of cancer molecular biology at UCL, who led the study, the evidence shows that this combination has resulted in breakthrough treatment for cancer. Drug resistant breast cancer and promising for many other types of cancer.

In the experiment, the combined effects of these two familiar cancer drugs have prevented the diseased cells from dividing and quickly aging, as well as removing the barriers that previous drug resistance that caused.

In breast cancer, the crizotinib treatment for lung cancer directly targets a protein that causes resistance to palbociclib cancer drugs.

"Cancer's adaptability, evolution and resistance are the biggest challenge we face in creating more effective treatments for this disease," said Professor Workman.